SalesTarget.ai — AI-Powered Sales Intelligence Operating System
Find & Enrich with 840M+ profiles. Validate contacts. Reach buyers on Email and LinkedIn. Close with a CRM built for salespeople — Power Dialer included.
SalesTarget.ai is a Sales OS built for outbound-driven B2B companies, agencies, and modern revenue teams. It centralizes every stage of the sales workflow — from data intelligence and enrichment to outreach, pipeline management, and AI assistance — eliminating the need for multiple disconnected tools.
At its core, the Intelligence Engine delivers prospecting power via 840M+ profiles, 150M+ company entities, 4,000+ data signals, and 50+ premium data providers — including real-time intent signals that surface in-market buyers before your competitors do.
Key capabilities:
Cold Email Outreach — smart sending, warm-up sequences, spintax & unified inbox
Power Dialer — auto-sequential dialing directly from the CRM
LinkedIn Automation — connection requests, InMail & multichannel drip sequences
Built-in Email Validation — reduce bounces & protect sender reputation
Integrated CRM — pipeline, deals, call logs, tasks & team collaboration
AI Co-pilot — find leads, build sequences & launch campaigns via simple chat commands
Intelligence → Enrichment → Validation → Email → Power Dialer → LinkedIn → CRM → AI Co-pilot. One platform. Infinite scale.
Learn more
Shape Software's purpose-built sales and marketing automation software empowers you to manage all aspects of your business from one platform.
The cloud-based software from Shape offers many tools to help you manage and automate your online marketing, promotions via text, email and digital marketing ads, capture leads from online sources, nurture prospects and customers and project manage your day. You can also offer customers a secure portal to streamline your intake processes, systematically score leads with ShapeIQ, and run detailed custom reporting.
Start growing your revenue with Shape's flexible suite of services today.
Learn more
Orbit BioSequence
Orbit BioSequence from Questel is an advanced tool for intellectual property (IP) intelligence, tailored to assist researchers, patent experts, and biotech firms in the thorough analysis and management of biological sequence data within the IP realm. This software presents a sophisticated framework for scrutinizing, analyzing, and keeping track of nucleotide and protein sequences identified in patent documents, thereby providing users with unprecedented access to vital sequence information that is essential for fostering innovation and conducting competitive assessments. With Orbit BioSequence, users can execute highly precise similarity and identity searches throughout international patent databases, empowering organizations to pinpoint existing patents, mitigate infringement risks, and discover potential licensing or collaboration opportunities. Furthermore, the software employs state-of-the-art search algorithms alongside meticulously curated datasets, guaranteeing both accuracy and relevance in the results. The comprehensive nature of this tool positions it as an invaluable resource in the evolving landscape of biotechnology and intellectual property management.
Learn more
Evo 2
Evo 2 represents a cutting-edge genomic foundation model that excels in making predictions and designing tasks related to DNA, RNA, and proteins. It employs an advanced deep learning architecture that allows for the modeling of biological sequences with single-nucleotide accuracy, achieving impressive scaling of both compute and memory resources as the context length increases. With a robust training of 40 billion parameters and a context length of 1 megabase, Evo 2 has analyzed over 9 trillion nucleotides sourced from a variety of eukaryotic and prokaryotic genomes. This extensive dataset facilitates Evo 2's ability to conduct zero-shot function predictions across various biological types, including DNA, RNA, and proteins, while also being capable of generating innovative sequences that maintain a plausible genomic structure. The model's versatility has been showcased through its effectiveness in designing operational CRISPR systems and in the identification of mutations that could lead to diseases in human genes. Furthermore, Evo 2 is available to the public on Arc's GitHub repository, and it is also incorporated into the NVIDIA BioNeMo framework, enhancing its accessibility for researchers and developers alike. Its integration into existing platforms signifies a major step forward for genomic modeling and analysis.
Learn more
